<html>
<head>
  <title>SARS-CoV-2 RNA-dependent RNA polymerase member protein of the core replicase complex (a.k.a. NSP12) (RdRp) gene V556L literature reference collection</title>
  <link rel="stylesheet" href="constellations.css">
</head>
<body>
<h1><a href="front.html">SARS-CoV-2</a> <a href="RdRp.html">RNA-dependent RNA polymerase member protein of the core replicase complex (a.k.a. NSP12) (RdRp)</a> gene <span class="constellation">RdRp:p.V556L</span> literature reference collection</h1>
<div class="effect_section"><h2 id="pharmaceutical_effectiveness">Pharmaceutical effectiveness</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Confers significant (5x) resistance in vitro to remdesivir [coordinates mapped from reported V553L in murine hepatitis virus model experiment to SARS-CoV-2].<br/> (<a href="https://doi.org/10.1128/mBio.00221-18" class="lit_link">Agostini et al. (2018)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> V556L mutation (incorrectly listed as V557L in the paper) is implicated in low-level resistance to Remdesivir.<br/> (<a href="https://doi.org/10.1074/jbc.AC120.015720" class="lit_link">Tchesnokov et al. (2020)</a>)</span></li>
</ul></div>
<div class="acknowledgement">Automatically generated using text2ui script and data from <a href="https://github.com/nodrogluap/pokay">Pokay</a></div>
</body>
</html>
